Ethics of Surrogacy During COVID-19 Pandemic
By Cathy Sakimura and Emily Galpern,
Men Having Babies
| 05. 12. 2021
The COVID pandemic has placed new hurdles to having a child through surrogacy, complicating international surrogacy in particular by restricting travel, delaying birth certificates and visas, and introducing specific considerations about safety and well-being. In addition, the pandemic has created new challenges to engaging in international surrogacy ethically due to changes in how healthcare is administered, limiting face-to-face interactions, and of course, increasing the health risks for everyone involved – women and other people acting as surrogates and egg donors, genetic intended parents undergoing medical procedures, and babies born through surrogacy. These challenges continue even as the landscape of the pandemic changes, given variation between countries in vaccination access.
What does it mean to approach international surrogacy ethically? An ethical approach strives to minimize the effects of gender, economic, global, and racial inequities that impact the bargaining power of people acting as surrogate or egg donors. The vast majority of people acting as surrogates and egg donors are women, and addressing the impact of gender inequality and the control and regulation of women’s bodies are core aspects of an ethical...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...